MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

mbp running on no news!

  1. 207 Posts.
    The only thing i can ascertain here is that any news forthcoming would be re talks with the FDA on phase II/III trial protocols, and also results of animal toxicity studies, but these are not significant enough in themselves...and there have been no timelines set as to the start date of the nxt trials...so i can't understand the reason for the sudden and meteoric rise.

    Can anyone tell me something i'm not aware of?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.